Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
about
Modern Clinical Research on LSD.The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.Beyond serotonin: newer antidepressants in the future.LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Serotonin and brain function: a tale of two receptorsNeuroticism is associated with challenging experiences with psilocybin mushrooms.Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.Potential Therapeutic Effects of Psilocybin.Therapeutic Applications of Classic Hallucinogens.Back to the future: Research renewed on the clinical utility of psychedelic drugs.The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.The Effects of Hallucinogens on Gene Expression.Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents.Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psycho-existential distress in cancer patients: A return to "entheogens".The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.Taking Psychedelics Seriously.Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.Long-lasting subjective effects of LSD in normal subjects.The role of psychedelics in palliative care reconsidered: A case for psilocybin.The successful return of psychedelics to psychiatry.Psilocybin for depression and anxiety associated with life-threatening illnesses.Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.Lessons to be learned from early psychedelic therapy in Denmark.Should addiction researchers be interested in psychedelic science?The hidden therapist: evidence for a central role of music in psychedelic therapy.The relationships of classic psychedelic use with criminal behavior in the United States adult population.Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Psilocybin: Good Trip or Bad Trip.
P2860
Q30401421-4DE3A802-1B91-436C-A971-0DB45C87701CQ33902992-3FA8A61F-D927-4547-8593-CB01879E0FB9Q34557706-9ED1360A-5632-4D93-9FA2-04FF45E2B6E8Q38373370-44EB17A7-65CC-4EE3-BAC0-DDC5BBB51E4DQ38378860-A23E0874-5505-48E0-B16A-E89B7D8E6359Q38600048-421A6E78-E3E2-47F4-9063-EEAFF19B244AQ38638190-12FFB4B2-6370-4288-833A-705088B966FEQ38645170-9B65C086-415C-4728-BC16-F0BE71584441Q38690821-F52153A5-EB7C-4188-AFAB-245B79B425B2Q38741517-251501EF-78E4-4D47-B425-65DF2C277DE6Q38781678-084D4F31-99BC-4327-A814-EA210CA2F599Q38788397-DC9E17CB-7F15-4061-BDFB-A2E54025F5F2Q38794300-FAE512D9-A72C-4ADA-86EA-8744755E6AFBQ39237019-252650F4-14B1-4051-A469-C929DED41384Q39290453-40F002E1-A3BA-488F-808C-CC28D509A310Q39414457-9B55FEDA-7229-4516-A1BF-27068D88FD95Q42359901-8DB52BA9-6A4B-47E3-AC20-D436377A5C7BQ42377130-4E0602F4-9107-4B66-8927-63A8E83729BDQ45065924-C914891E-B14A-4CEA-A8A6-B03D6E743561Q47197626-51817C5A-24A0-4B27-955E-2AAB916E2F47Q47287851-465A5BF2-602E-4D0A-97FD-80572CB7062EQ47550103-C60367BC-83DE-4A54-AD56-2A9C831C7962Q47577495-2F79E0E1-59BE-4439-B7EB-A94DA66A427FQ47611811-CCAD40E9-7E93-4C13-9640-CFC23E98AADBQ47640031-A85C3E7A-0FC7-4D1A-8ACF-B098ED098A6DQ47649975-690DD5C6-B070-47AC-891B-921CFC942F61Q47654338-FD53362D-0C9B-4867-8AE5-F206D399E33FQ47682915-AE446EBB-1DB6-48F8-989F-5DB797801953Q47690853-3B0879DD-7775-4CEB-A6AC-84D372EE7838Q47691384-1C1B6714-A63F-4B28-9116-59B3819C4C8CQ47862941-FE483717-C08B-4CD9-8E5A-508FF3EF834CQ47862959-545628BA-8F03-4E1C-A299-8737960D3C54Q47862978-BA0D1026-61C2-4FAD-AD9F-91CD66885807Q48023125-BF60A81B-D86F-423F-B743-C45190DFF4DDQ48187582-63C04D74-7376-4D01-B483-24CA806FCE00Q48292506-FE4275AF-1C4B-4ABE-A5F7-AEC63BB7D66CQ49357192-AF9EB040-FFEB-4D6C-868E-FE5EC0C9AD83Q50078290-79175F2B-351F-4DA6-8D0C-DDA929BB9BB5Q50095081-A43CF2B5-A95F-4334-9155-07F8782F04FFQ50620893-68FB20E7-F650-4513-ADBC-24216316D161
P2860
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Psilocybin produces substantia ...... randomized double-blind trial.
@ast
Psilocybin produces substantia ...... randomized double-blind trial.
@en
type
label
Psilocybin produces substantia ...... randomized double-blind trial.
@ast
Psilocybin produces substantia ...... randomized double-blind trial.
@en
prefLabel
Psilocybin produces substantia ...... randomized double-blind trial.
@ast
Psilocybin produces substantia ...... randomized double-blind trial.
@en
P2093
P2860
P356
P1476
Psilocybin produces substantia ...... randomized double-blind trial.
@en
P2093
Annie Umbricht
Brian D Richards
Margaret A Klinedinst
Mary P Cosimano
Matthew W Johnson
Michael A Carducci
Roland R Griffiths
William A Richards
P2860
P304
P356
10.1177/0269881116675513
P407
P577
2016-12-01T00:00:00Z